AI Healthcare AI Stocks
AI healthcare stocks apply artificial intelligence to drug discovery, diagnostics, and healthcare delivery. Models now design drug candidates, read medical images, and draft clinical documentation, and the layer spans AI-research pharma, diagnostics platforms, and medical devices whose core function depends on machine learning.
Market Cap
$2.52T
AI-Exposed Cap
$411.01B
24h Change
-0.73%
7d Change
+1.56%
Stocks
34
Market data as of the close on . Prices are end of day, not live.
# | Name | Price | 24h | 7d | Market Cap | Volume (24h) | 7d Chart |
|---|---|---|---|---|---|---|---|
| 1 | L LLY | $1,150.99 | -1.19% | +1.31% | $1.03T | $2.5B | |
| 2 | J JNJ | $269.17 | -0.11% | +0.74% | $648.67B | $1.7B | |
| 3 | A AZN | $163.33 | -2.84% | +0.91% | $253.31B | $385.6M | |
| 4 | I ISRG | $398.30 | -0.83% | +5.61% | $142.70B | $668.4M | |
| 5 | S SYK | $273.40 | -0.29% | -2.88% | $142.00B | $706.6M | |
| 6 | N NTRA | $390.79 | +5.44% | +11.41% | $56.33B | $657.0M | |
| 7 | S SMMNY | $21.10 | -3.21% | -5.68% | $47.23B | $457.7K | |
| 8 | I ILMN | $255.38 | +6.93% | +14.89% | $38.56B | $586.7M | |
| 9 | D DXCM | $87.73 | -1.61% | +1.48% | $33.11B | $318.0M | |
| 10 | G GEHC | $66.09 | +1.98% | +3.15% | $29.85B | $203.4M | |
| 11 | P PEN | $319.44 | +0.21% | +0.32% | $12.58B | $131.2M | |
| 12 | A ALGN | $148.17 | +0.88% | +0.80% | $10.53B | $195.7M | |
| 13 | G GMED | $73.96 | -0.44% | -0.98% | $9.93B | $107.7M | |
| 14 | T TEM | $76.59 | -0.78% | +9.46% | $9.40B | $410.1M | |
| 15 | C CAI | $31.65 | +3.26% | +11.05% | $8.95B | $138.0M | |
| 16 | H HNGE | $92.28 | -2.30% | -0.12% | $7.45B | $157.1M | |
| 17 | R RDNT | $73.21 | +0.74% | -5.07% | $5.76B | $41.0M | |
| 18 | H HTFL | $47.39 | -5.84% | -1.94% | $4.12B | $99.4M | |
| 19 | A ABCL | $12.31 | -2.76% | +7.89% | $3.99B | $47.4M | |
| 20 | R RLAY | $18.03 | -0.88% | -4.96% | $3.95B | $84.8M | |
| 21 | I IRTC | $111.75 | +1.24% | -0.12% | $3.68B | $137.0M | |
| 22 | O OSIS | $203.00 | +1.30% | +0.20% | $3.24B | $43.3M | |
| 23 | T TWST | $158.50 | -4.42% | +14.77% | $2.60B | $338.1M | |
| 24 | B BFLY | $9.20 | -7.35% | +26.72% | $2.45B | $71.6M | |
| 25 | T TXG | $75.62 | -4.40% | +1.65% | $2.20B | $262.6M | |
| 26 | S SDGR | $29.23 | -3.34% | +25.72% | $2.19B | $89.5M | |
| 27 | R RXRX | $3.70 | -8.64% | +15.99% | $1.98B | $87.2M | |
| 28 | A ABSI | $9.74 | -0.76% | +22.73% | $1.67B | $45.9M | |
| 29 | C CERT | $8.64 | +1.41% | +2.86% | $1.32B | $21.5M | |
| 30 | P PRCT | $18.09 | -2.27% | -6.27% | $1.03B | $16.5M | |
| 31 | S SOPH | $8.08 | -1.94% | +1.51% | $687.83M | $4.5M | |
| 32 | V VREX | $18.45 | -0.11% | -0.11% | $590.00M | $7.2M | |
| 33 | C CARL | $14.76 | -5.38% | -3.09% | $402.99M | $912.6K | |
| 34 | N NNOX | $0.70 | -5.32% | +1.57% | $54.84M | $734.2K |
Frequently asked questions
How is AI actually used in drug discovery?
Models predict protein structures, generate and screen candidate molecules, and prioritize targets, compressing steps that once took years of laboratory iteration. Large pharmaceutical companies now run AI-first discovery programs and partner with AI labs, and the first AI-designed candidates have reached human trials.
What makes healthcare AI different from other AI investing?
Regulation and evidence. Medical AI needs clinical validation and regulatory clearance, which slows adoption but also protects it: an approved, reimbursed AI product faces far less competition than a consumer app. Timelines are longer, and the winners tend to be stickier.
New to the framework? The Start Here guide walks the whole buildout layer by layer, including where AI Healthcare fits.